BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3017368)

  • 1. Phosphoribosylpyrophosphate synthetase superactivity. A study of five patients with catalytic defects in the enzyme.
    Becker MA; Losman MJ; Rosenberg AL; Mehlman I; Levinson DJ; Holmes EW
    Arthritis Rheum; 1986 Jul; 29(7):880-8. PubMed ID: 3017368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gout with superactive phosphoribosylpyrophosphate synthetase due to increased enzyme catalytic rate.
    Becker MA; Losman MJ; Itkin P; Simkin PA
    J Lab Clin Med; 1982 Apr; 99(4):495-511. PubMed ID: 6174658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inherited superactivity of phosphoribosylpyrophosphate synthetase: association of uric acid overproduction and sensorineural deafness.
    Becker MA; Puig JG; Mateos FA; Jimenez ML; Kim M; Simmonds HA
    Am J Med; 1988 Sep; 85(3):383-90. PubMed ID: 2843048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant feedback-resistant phosphoribosylpyrophosphate synthetase associated with purine overproduction and gout. Phosphoribosylpyrophosphate and purine metabolism in cultured fibroblasts.
    Zoref E; De Vries A; Sperling O
    J Clin Invest; 1975 Nov; 56(5):1093-9. PubMed ID: 171280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective expression of phosphoribosylpyrophosphate synthetase superactivity in human lymphoblast lines.
    Losman MJ; Rimon D; Kim M; Becker MA
    J Clin Invest; 1985 Oct; 76(4):1657-64. PubMed ID: 2414323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human phosphoribosylpyrophosphate synthetase: radioimmunochemical quantitation in erythrocytes and fibroblasts.
    Itkin P; Woo S; Becker MA
    J Lab Clin Med; 1984 Jul; 104(1):96-109. PubMed ID: 6330252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variant human phosphoribosylpyrophosphate synthetase altered in regulatory and catalytic functions.
    Becker MA; Raivio KO; Bakay B; Adams WB; Nyhan WL
    J Clin Invest; 1980 Jan; 65(1):109-20. PubMed ID: 6243137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [PRPP synthetase superactivity].
    Fujimori S
    Nihon Rinsho; 1996 Dec; 54(12):3309-14. PubMed ID: 8976111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of accelerated purine nucleotide synthesis in human fibroblasts with superactive phosphoribosylpyrophosphate synthetases.
    Becker MA; Losman MJ; Kim M
    J Biol Chem; 1987 Apr; 262(12):5596-602. PubMed ID: 3032938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurodevelopmental impairment and deranged PRPP and purine nucleotide synthesis in inherited superactivity of PRPP synthetase.
    Becker MA; Puig JG; Mateos FA; Jimenez ML; Kim M; Simmonds HA
    Adv Exp Med Biol; 1989; 253A():15-22. PubMed ID: 2483028
    [No Abstract]   [Full Text] [Related]  

  • 11. Superactivity of phosphoribosylpyrophosphate synthetase, due to feedback resistance, causing purine overproduction and gout.
    Sperling O; Boer P; Brosh S; Zoref E; de Vries A
    Ciba Found Symp; 1977; (48):143-64. PubMed ID: 204460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superactivity of human phosphoribosyl pyrophosphate synthetase due to altered regulation by nucleotide inhibitors and inorganic phosphate.
    Becker MA; Losman MJ; Wilson J; Simmonds HA
    Biochim Biophys Acta; 1986 Jun; 882(2):168-76. PubMed ID: 2423135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overproduction disease in man due to enzyme feedback resistance mutation. Purine overproduction in gout due to excessive activity of mutant feedback-resistant phosphoribosylpyrophosphate synthetase.
    Sperling O; Boer P; Brosh S; Zoref E; de Vries A
    Enzyme; 1978; 23(1):1-9. PubMed ID: 203449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic evaluation of phosphoribosylpyrophosphate synthetase activities in hemolysates.
    Losman MJ; Hecker S; Woo S; Becker MA
    J Lab Clin Med; 1984 Jun; 103(6):932-43. PubMed ID: 6327865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of phosphoribosylpyrophosphate and ribose-5-phosphate concentration and generation in fibroblasts from patients with gout and purine overproduction.
    Becker MA
    J Clin Invest; 1976 Feb; 57(2):308-18. PubMed ID: 176178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superactive phosphoribosylpyrophosphate synthetase with altered regulatory and catalytic properties.
    Becker MA; Raivio KO; Bakay B; Adams WB; Nyhan WL
    Adv Exp Med Biol; 1980; 122A():387-92. PubMed ID: 6158850
    [No Abstract]   [Full Text] [Related]  

  • 17. Alterations in purine metabolism in cultured fibroblasts with HGPRT deficiency and with PRPP synthetase superactivity.
    Zoref-Shani E; Sperling O
    Adv Exp Med Biol; 1979; 122B():19-24. PubMed ID: 232629
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased purine nucleotide degradation in the central nervous system (CNS) in PRPP synthetase superactivity.
    Jiménez ML; Puig JG; Mateos FA; Ramos TH; Melián JS; Nieto VG; Becker MA
    Adv Exp Med Biol; 1989; 253A():9-13. PubMed ID: 2560341
    [No Abstract]   [Full Text] [Related]  

  • 19. Accelerated transcription of PRPS1 in X-linked overactivity of normal human phosphoribosylpyrophosphate synthetase.
    Ahmed M; Taylor W; Smith PR; Becker MA
    J Biol Chem; 1999 Mar; 274(11):7482-8. PubMed ID: 10066814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphoribosylpyrophosphate synthesis in cultured human cells.
    Benke PJ; Dittmar D
    Science; 1977 Dec; 198(4322):1171-3. PubMed ID: 201027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.